Jenoptik Future Growth
Future criteria checks 1/6
Jenoptik is forecast to grow earnings and revenue by 12.3% and 4.4% per annum respectively. EPS is expected to grow by 12.2% per annum. Return on equity is forecast to be 11.6% in 3 years.
Key information
12.3%
Earnings growth rate
12.2%
EPS growth rate
| Electronic earnings growth | 41.1% |
| Revenue growth rate | 4.4% |
| Future return on equity | 11.6% |
| Analyst coverage | Good |
| Last updated | 20 Nov 2024 |
Recent future growth updates
Recent updates
Earnings Beat: Jenoptik AG Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
Nov 15
Jenoptik AG's (ETR:JEN) 28% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/ERatio
Nov 14Is Jenoptik AG (ETR:JEN) Trading At A 47% Discount?
Oct 14Is There Now An Opportunity In Jenoptik AG (ETR:JEN)?
Sep 28Market Participants Recognise Jenoptik AG's (ETR:JEN) Earnings
Aug 15Here's Why Shareholders May Want To Be Cautious With Increasing Jenoptik AG's (ETR:JEN) CEO Pay Packet
Jun 12Does Jenoptik (ETR:JEN) Have A Healthy Balance Sheet?
May 30Jenoptik (ETR:JEN) Will Pay A Larger Dividend Than Last Year At €0.35
Apr 25Jenoptik AG's (ETR:JEN) P/E Is On The Mark
Apr 15Jenoptik's (ETR:JEN) Upcoming Dividend Will Be Larger Than Last Year's
Mar 30At €30.04, Is Jenoptik AG (ETR:JEN) Worth Looking At Closely?
Mar 22Getting In Cheap On Jenoptik AG (ETR:JEN) Might Be Difficult
Jan 07Is Jenoptik (ETR:JEN) A Risky Investment?
Dec 20Why Jenoptik AG (ETR:JEN) Could Be Worth Watching
Dec 05Is It Too Late To Consider Buying Jenoptik AG (ETR:JEN)?
Sep 01Is There An Opportunity With Jenoptik AG's (ETR:JEN) 49% Undervaluation?
Aug 11Jenoptik (ETR:JEN) Has A Pretty Healthy Balance Sheet
Jul 25Jenoptik (ETR:JEN) Will Pay A Larger Dividend Than Last Year At €0.30
May 07We Think Jenoptik (ETR:JEN) Can Stay On Top Of Its Debt
Apr 04Should You Think About Buying Jenoptik AG (ETR:JEN) Now?
Feb 19Here's Why Jenoptik (ETR:JEN) Can Manage Its Debt Responsibly
Dec 06What Does Jenoptik AG's (ETR:JEN) Share Price Indicate?
Nov 13Is Jenoptik AG (ETR:JEN) Trading At A 27% Discount?
Oct 28Is Jenoptik (ETR:JEN) A Risky Investment?
Sep 02When Should You Buy Jenoptik AG (ETR:JEN)?
Aug 13We Think Jenoptik (ETR:JEN) Can Stay On Top Of Its Debt
May 19Is Now An Opportune Moment To Examine Jenoptik AG (ETR:JEN)?
May 01Does Jenoptik (ETR:JEN) Have A Healthy Balance Sheet?
Feb 14Is It Time To Consider Buying Jenoptik AG (ETR:JEN)?
Jan 23Is Jenoptik (ETR:JEN) Using Too Much Debt?
Nov 07At €32.08, Is It Time To Put Jenoptik AG (ETR:JEN) On Your Watch List?
Oct 23Here's What To Make Of Jenoptik's (ETR:JEN) Decelerating Rates Of Return
Sep 23Estimating The Fair Value Of Jenoptik AG (ETR:JEN)
Aug 28Is Jenoptik (ETR:JEN) Using Too Much Debt?
Jul 27Is It Too Late To Consider Buying Jenoptik AG (ETR:JEN)?
Jul 13The Returns On Capital At Jenoptik (ETR:JEN) Don't Inspire Confidence
May 17Calculating The Intrinsic Value Of Jenoptik AG (ETR:JEN)
May 04Jenoptik's (ETR:JEN) Conservative Accounting Might Explain Soft Earnings
Apr 01Does Jenoptik (ETR:JEN) Have A Healthy Balance Sheet?
Mar 27Here's What Jenoptik AG's (ETR:JEN) Shareholder Ownership Structure Looks Like
Mar 14Is Jenoptik AG (ETR:JEN) The Right Choice For A Smart Dividend Investor?
Mar 02Investors Who Bought Jenoptik (ETR:JEN) Shares Five Years Ago Are Now Up 140%
Feb 17Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 1,204 | 117 | 105 | 189 | 7 |
| 12/31/2025 | 1,140 | 96 | 97 | 181 | 9 |
| 12/31/2024 | 1,117 | 92 | 52 | 155 | 9 |
| 9/30/2024 | 1,112 | 84 | 100 | 190 | N/A |
| 6/30/2024 | 1,102 | 80 | 102 | 184 | N/A |
| 3/31/2024 | 1,088 | 76 | 69 | 155 | N/A |
| 12/31/2023 | 1,066 | 73 | 79 | 167 | N/A |
| 9/30/2023 | 1,051 | 70 | 72 | 154 | N/A |
| 6/30/2023 | 1,038 | 68 | 69 | 152 | N/A |
| 3/31/2023 | 1,006 | 70 | 87 | 170 | N/A |
| 12/31/2022 | 981 | 62 | 63 | 143 | N/A |
| 9/30/2022 | 929 | 75 | 56 | 130 | N/A |
| 6/30/2022 | 869 | 81 | 48 | 113 | N/A |
| 3/31/2022 | 809 | 91 | 38 | 92 | N/A |
| 12/31/2021 | 751 | 91 | 52 | 98 | N/A |
| 9/30/2021 | 630 | 69 | 56 | 101 | N/A |
| 6/30/2021 | 616 | 58 | 47 | 89 | N/A |
| 3/31/2021 | 602 | 37 | 48 | 87 | N/A |
| 12/31/2020 | 615 | 33 | 46 | 90 | N/A |
| 9/30/2020 | 765 | 48 | 69 | 113 | N/A |
| 6/30/2020 | 801 | 54 | 94 | 143 | N/A |
| 3/31/2020 | 836 | 57 | 84 | 136 | N/A |
| 12/31/2019 | 855 | 68 | 64 | 109 | N/A |
| 9/30/2019 | 837 | 78 | 43 | 90 | N/A |
| 6/30/2019 | 833 | 78 | 47 | 91 | N/A |
| 3/31/2019 | 829 | 82 | 75 | 118 | N/A |
| 12/31/2018 | 835 | 88 | 94 | 135 | N/A |
| 9/30/2018 | 814 | 82 | 81 | 119 | N/A |
| 6/30/2018 | 784 | 83 | N/A | 97 | N/A |
| 3/31/2018 | 774 | 80 | N/A | 95 | N/A |
| 12/31/2017 | 748 | 73 | N/A | 96 | N/A |
| 9/30/2017 | 719 | 62 | N/A | 94 | N/A |
| 6/30/2017 | 706 | 55 | N/A | 107 | N/A |
| 3/31/2017 | 690 | 56 | N/A | 103 | N/A |
| 12/31/2016 | 685 | 54 | N/A | 100 | N/A |
| 9/30/2016 | 674 | 51 | N/A | 108 | N/A |
| 6/30/2016 | 679 | 51 | N/A | 102 | N/A |
| 3/31/2016 | 681 | 48 | N/A | 101 | N/A |
| 12/31/2015 | 669 | 49 | N/A | 85 | N/A |
| 9/30/2015 | 658 | 46 | N/A | 69 | N/A |
| 6/30/2015 | 623 | 40 | N/A | 72 | N/A |
| 3/31/2015 | 599 | 39 | N/A | 53 | N/A |
| 12/31/2014 | 590 | 38 | N/A | 46 | N/A |
| 9/30/2014 | 588 | 42 | N/A | 56 | N/A |
| 6/30/2014 | 600 | 45 | N/A | 37 | N/A |
| 3/31/2014 | 605 | 44 | N/A | 41 | N/A |
| 12/31/2013 | 600 | 44 | N/A | 61 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: JEN's forecast earnings growth (12.3% per year) is above the savings rate (1%).
Earnings vs Market: JEN's earnings (12.3% per year) are forecast to grow slower than the German market (21% per year).
High Growth Earnings: JEN's earnings are forecast to grow, but not significantly.
Revenue vs Market: JEN's revenue (4.4% per year) is forecast to grow slower than the German market (5.6% per year).
High Growth Revenue: JEN's revenue (4.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: JEN's Return on Equity is forecast to be low in 3 years time (11.6%).